Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body's specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body's protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.

The global Oral Vaccine Adjuvants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oral Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccine Adjuvants.

Report Scope

The Oral Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Vaccine Adjuvants Market Report

Report Metric	Details
Report Name	Oral Vaccine Adjuvants Market
CAGR	5%
Segment by Type	Veterinary Vaccine Adjuvants Human Vaccine Adjuvants
Segment by Application	Research Application Commercial Application
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL, Brenntag Biosector, Avanti Polar Lipids
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Vaccine Adjuvants Market report?

Ans: The main players in the Oral Vaccine Adjuvants Market are SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL, Brenntag Biosector, Avanti Polar Lipids

What are the Application segmentation covered in the Oral Vaccine Adjuvants Market report?

Ans: The Applications covered in the Oral Vaccine Adjuvants Market report are Research Application, Commercial Application

What are the Type segmentation covered in the Oral Vaccine Adjuvants Market report?

Ans: The Types covered in the Oral Vaccine Adjuvants Market report are Veterinary Vaccine Adjuvants, Human Vaccine Adjuvants

1 Oral Vaccine Adjuvants Market Overview

1.1 Product Overview and Scope of Oral Vaccine Adjuvants

1.2 Oral Vaccine Adjuvants Segment by Type

1.2.1 Global Oral Vaccine Adjuvants Market Value Comparison by Type (2024-2030)

1.2.2 Veterinary Vaccine Adjuvants

1.2.3 Human Vaccine Adjuvants

1.3 Oral Vaccine Adjuvants Segment by Application

1.3.1 Global Oral Vaccine Adjuvants Market Value by Application: (2024-2030)

1.3.2 Research Application

1.3.3 Commercial Application

1.4 Global Oral Vaccine Adjuvants Market Size Estimates and Forecasts

1.4.1 Global Oral Vaccine Adjuvants Revenue 2019-2030

1.4.2 Global Oral Vaccine Adjuvants Sales 2019-2030

1.4.3 Global Oral Vaccine Adjuvants Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Oral Vaccine Adjuvants Market Competition by Manufacturers

2.1 Global Oral Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)

2.2 Global Oral Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Oral Vaccine Adjuvants Average Price by Manufacturers (2019-2024)

2.4 Global Oral Vaccine Adjuvants Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Vaccine Adjuvants, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Vaccine Adjuvants, Product Type & Application

2.7 Oral Vaccine Adjuvants Market Competitive Situation and Trends

2.7.1 Oral Vaccine Adjuvants Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Oral Vaccine Adjuvants Players Market Share by Revenue

2.7.3 Global Oral Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oral Vaccine Adjuvants Retrospective Market Scenario by Region

3.1 Global Oral Vaccine Adjuvants Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Oral Vaccine Adjuvants Global Oral Vaccine Adjuvants Sales by Region: 2019-2030

3.2.1 Global Oral Vaccine Adjuvants Sales by Region: 2019-2024

3.2.2 Global Oral Vaccine Adjuvants Sales by Region: 2025-2030

3.3 Global Oral Vaccine Adjuvants Global Oral Vaccine Adjuvants Revenue by Region: 2019-2030

3.3.1 Global Oral Vaccine Adjuvants Revenue by Region: 2019-2024

3.3.2 Global Oral Vaccine Adjuvants Revenue by Region: 2025-2030

3.4 North America Oral Vaccine Adjuvants Market Facts & Figures by Country

3.4.1 North America Oral Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Oral Vaccine Adjuvants Sales by Country (2019-2030)

3.4.3 North America Oral Vaccine Adjuvants Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oral Vaccine Adjuvants Market Facts & Figures by Country

3.5.1 Europe Oral Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Oral Vaccine Adjuvants Sales by Country (2019-2030)

3.5.3 Europe Oral Vaccine Adjuvants Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Vaccine Adjuvants Market Facts & Figures by Country

3.6.1 Asia Pacific Oral Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Oral Vaccine Adjuvants Sales by Country (2019-2030)

3.6.3 Asia Pacific Oral Vaccine Adjuvants Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Oral Vaccine Adjuvants Market Facts & Figures by Country

3.7.1 Latin America Oral Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Oral Vaccine Adjuvants Sales by Country (2019-2030)

3.7.3 Latin America Oral Vaccine Adjuvants Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Vaccine Adjuvants Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Oral Vaccine Adjuvants Sales by Country (2019-2030)

3.8.3 Middle East and Africa Oral Vaccine Adjuvants Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oral Vaccine Adjuvants Sales by Type (2019-2030)

4.1.1 Global Oral Vaccine Adjuvants Sales by Type (2019-2024)

4.1.2 Global Oral Vaccine Adjuvants Sales by Type (2025-2030)

4.1.3 Global Oral Vaccine Adjuvants Sales Market Share by Type (2019-2030)

4.2 Global Oral Vaccine Adjuvants Revenue by Type (2019-2030)

4.2.1 Global Oral Vaccine Adjuvants Revenue by Type (2019-2024)

4.2.2 Global Oral Vaccine Adjuvants Revenue by Type (2025-2030)

4.2.3 Global Oral Vaccine Adjuvants Revenue Market Share by Type (2019-2030)

4.3 Global Oral Vaccine Adjuvants Price by Type (2019-2030)

5 Segment by Application

5.1 Global Oral Vaccine Adjuvants Sales by Application (2019-2030)

5.1.1 Global Oral Vaccine Adjuvants Sales by Application (2019-2024)

5.1.2 Global Oral Vaccine Adjuvants Sales by Application (2025-2030)

5.1.3 Global Oral Vaccine Adjuvants Sales Market Share by Application (2019-2030)

5.2 Global Oral Vaccine Adjuvants Revenue by Application (2019-2030)

5.2.1 Global Oral Vaccine Adjuvants Revenue by Application (2019-2024)

5.2.2 Global Oral Vaccine Adjuvants Revenue by Application (2025-2030)

5.2.3 Global Oral Vaccine Adjuvants Revenue Market Share by Application (2019-2030)

5.3 Global Oral Vaccine Adjuvants Price by Application (2019-2030)

6 Key Companies Profiled

6.1 SEPPIC

6.1.1 SEPPIC Corporation Information

6.1.2 SEPPIC Description and Business Overview

6.1.3 SEPPIC Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.1.4 SEPPIC Oral Vaccine Adjuvants Product Portfolio

6.1.5 SEPPIC Recent Developments/Updates

6.2 SDA BIO

6.2.1 SDA BIO Corporation Information

6.2.2 SDA BIO Description and Business Overview

6.2.3 SDA BIO Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.2.4 SDA BIO Oral Vaccine Adjuvants Product Portfolio

6.2.5 SDA BIO Recent Developments/Updates

6.3 Croda International

6.3.1 Croda International Corporation Information

6.3.2 Croda International Description and Business Overview

6.3.3 Croda International Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Croda International Oral Vaccine Adjuvants Product Portfolio

6.3.5 Croda International Recent Developments/Updates

6.4 SPI Pharma

6.4.1 SPI Pharma Corporation Information

6.4.2 SPI Pharma Description and Business Overview

6.4.3 SPI Pharma Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.4.4 SPI Pharma Oral Vaccine Adjuvants Product Portfolio

6.4.5 SPI Pharma Recent Developments/Updates

6.5 Phibro Animal Health Corporation

6.5.1 Phibro Animal Health Corporation Corporation Information

6.5.2 Phibro Animal Health Corporation Description and Business Overview

6.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Product Portfolio

6.5.5 Phibro Animal Health Corporation Recent Developments/Updates

6.6 Tj Kaiwei

6.6.1 Tj Kaiwei Corporation Information

6.6.2 Tj Kaiwei Description and Business Overview

6.6.3 Tj Kaiwei Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Tj Kaiwei Oral Vaccine Adjuvants Product Portfolio

6.6.5 Tj Kaiwei Recent Developments/Updates

6.7 Novavax

6.6.1 Novavax Corporation Information

6.6.2 Novavax Description and Business Overview

6.6.3 Novavax Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novavax Oral Vaccine Adjuvants Product Portfolio

6.7.5 Novavax Recent Developments/Updates

6.8 Zhuoyue

6.8.1 Zhuoyue Corporation Information

6.8.2 Zhuoyue Description and Business Overview

6.8.3 Zhuoyue Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zhuoyue Oral Vaccine Adjuvants Product Portfolio

6.8.5 Zhuoyue Recent Developments/Updates

6.9 Aphios

6.9.1 Aphios Corporation Information

6.9.2 Aphios Description and Business Overview

6.9.3 Aphios Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Aphios Oral Vaccine Adjuvants Product Portfolio

6.9.5 Aphios Recent Developments/Updates

6.10 GSK

6.10.1 GSK Corporation Information

6.10.2 GSK Description and Business Overview

6.10.3 GSK Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.10.4 GSK Oral Vaccine Adjuvants Product Portfolio

6.10.5 GSK Recent Developments/Updates

6.11 CSL

6.11.1 CSL Corporation Information

6.11.2 CSL Oral Vaccine Adjuvants Description and Business Overview

6.11.3 CSL Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.11.4 CSL Oral Vaccine Adjuvants Product Portfolio

6.11.5 CSL Recent Developments/Updates

6.12 Brenntag Biosector

6.12.1 Brenntag Biosector Corporation Information

6.12.2 Brenntag Biosector Oral Vaccine Adjuvants Description and Business Overview

6.12.3 Brenntag Biosector Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Brenntag Biosector Oral Vaccine Adjuvants Product Portfolio

6.12.5 Brenntag Biosector Recent Developments/Updates

6.13 SEPPIC

6.13.1 SEPPIC Corporation Information

6.13.2 SEPPIC Oral Vaccine Adjuvants Description and Business Overview

6.13.3 SEPPIC Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.13.4 SEPPIC Oral Vaccine Adjuvants Product Portfolio

6.13.5 SEPPIC Recent Developments/Updates

6.14 SPI Pharma

6.14.1 SPI Pharma Corporation Information

6.14.2 SPI Pharma Oral Vaccine Adjuvants Description and Business Overview

6.14.3 SPI Pharma Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.14.4 SPI Pharma Oral Vaccine Adjuvants Product Portfolio

6.14.5 SPI Pharma Recent Developments/Updates

6.15 Novavax

6.15.1 Novavax Corporation Information

6.15.2 Novavax Oral Vaccine Adjuvants Description and Business Overview

6.15.3 Novavax Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Novavax Oral Vaccine Adjuvants Product Portfolio

6.15.5 Novavax Recent Developments/Updates

6.16 Avanti Polar Lipids

6.16.1 Avanti Polar Lipids Corporation Information

6.16.2 Avanti Polar Lipids Oral Vaccine Adjuvants Description and Business Overview

6.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Product Portfolio

6.16.5 Avanti Polar Lipids Recent Developments/Updates

6.17 Aphios

6.17.1 Aphios Corporation Information

6.17.2 Aphios Oral Vaccine Adjuvants Description and Business Overview

6.17.3 Aphios Oral Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Aphios Oral Vaccine Adjuvants Product Portfolio

6.17.5 Aphios Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Vaccine Adjuvants Industry Chain Analysis

7.2 Oral Vaccine Adjuvants Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Vaccine Adjuvants Production Mode & Process

7.4 Oral Vaccine Adjuvants Sales and Marketing

7.4.1 Oral Vaccine Adjuvants Sales Channels

7.4.2 Oral Vaccine Adjuvants Distributors

7.5 Oral Vaccine Adjuvants Customers

8 Oral Vaccine Adjuvants Market Dynamics

8.1 Oral Vaccine Adjuvants Industry Trends

8.2 Oral Vaccine Adjuvants Market Drivers

8.3 Oral Vaccine Adjuvants Market Challenges

8.4 Oral Vaccine Adjuvants Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

SDA BIO

Croda International

Phibro Animal Health Corporation

List of Tables

Table 1. Global Oral Vaccine Adjuvants Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Oral Vaccine Adjuvants Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Oral Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2023

Table 4. Global Oral Vaccine Adjuvants Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Oral Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Oral Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Oral Vaccine Adjuvants Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Oral Vaccine Adjuvants Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Oral Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Vaccine Adjuvants, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Vaccine Adjuvants, Product Type & Application

Table 12. Global Key Manufacturers of Oral Vaccine Adjuvants, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccine Adjuvants as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Vaccine Adjuvants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Oral Vaccine Adjuvants Sales by Region (2019-2024) & (K Units)

Table 18. Global Oral Vaccine Adjuvants Sales Market Share by Region (2019-2024)

Table 19. Global Oral Vaccine Adjuvants Sales by Region (2025-2030) & (K Units)

Table 20. Global Oral Vaccine Adjuvants Sales Market Share by Region (2025-2030)

Table 21. Global Oral Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Oral Vaccine Adjuvants Revenue Market Share by Region (2019-2024)

Table 23. Global Oral Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Oral Vaccine Adjuvants Revenue Market Share by Region (2025-2030)

Table 25. North America Oral Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Oral Vaccine Adjuvants Sales by Country (2019-2024) & (K Units)

Table 27. North America Oral Vaccine Adjuvants Sales by Country (2025-2030) & (K Units)

Table 28. North America Oral Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Oral Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Oral Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Oral Vaccine Adjuvants Sales by Country (2019-2024) & (K Units)

Table 32. Europe Oral Vaccine Adjuvants Sales by Country (2025-2030) & (K Units)

Table 33. Europe Oral Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Oral Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Oral Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Oral Vaccine Adjuvants Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Oral Vaccine Adjuvants Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Oral Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Oral Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Oral Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Oral Vaccine Adjuvants Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Oral Vaccine Adjuvants Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Oral Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oral Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Oral Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Oral Vaccine Adjuvants Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Oral Vaccine Adjuvants Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Oral Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Oral Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Oral Vaccine Adjuvants Sales (K Units) by Type (2019-2024)

Table 51. Global Oral Vaccine Adjuvants Sales (K Units) by Type (2025-2030)

Table 52. Global Oral Vaccine Adjuvants Sales Market Share by Type (2019-2024)

Table 53. Global Oral Vaccine Adjuvants Sales Market Share by Type (2025-2030)

Table 54. Global Oral Vaccine Adjuvants Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Oral Vaccine Adjuvants Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Oral Vaccine Adjuvants Revenue Market Share by Type (2019-2024)

Table 57. Global Oral Vaccine Adjuvants Revenue Market Share by Type (2025-2030)

Table 58. Global Oral Vaccine Adjuvants Price (US$/Unit) by Type (2019-2024)

Table 59. Global Oral Vaccine Adjuvants Price (US$/Unit) by Type (2025-2030)

Table 60. Global Oral Vaccine Adjuvants Sales (K Units) by Application (2019-2024)

Table 61. Global Oral Vaccine Adjuvants Sales (K Units) by Application (2025-2030)

Table 62. Global Oral Vaccine Adjuvants Sales Market Share by Application (2019-2024)

Table 63. Global Oral Vaccine Adjuvants Sales Market Share by Application (2025-2030)

Table 64. Global Oral Vaccine Adjuvants Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Oral Vaccine Adjuvants Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Oral Vaccine Adjuvants Revenue Market Share by Application (2019-2024)

Table 67. Global Oral Vaccine Adjuvants Revenue Market Share by Application (2025-2030)

Table 68. Global Oral Vaccine Adjuvants Price (US$/Unit) by Application (2019-2024)

Table 69. Global Oral Vaccine Adjuvants Price (US$/Unit) by Application (2025-2030)

Table 70. SEPPIC Corporation Information

Table 71. SEPPIC Description and Business Overview

Table 72. SEPPIC Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. SEPPIC Oral Vaccine Adjuvants Product

Table 74. SEPPIC Recent Developments/Updates

Table 75. SDA BIO Corporation Information

Table 76. SDA BIO Description and Business Overview

Table 77. SDA BIO Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. SDA BIO Oral Vaccine Adjuvants Product

Table 79. SDA BIO Recent Developments/Updates

Table 80. Croda International Corporation Information

Table 81. Croda International Description and Business Overview

Table 82. Croda International Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Croda International Oral Vaccine Adjuvants Product

Table 84. Croda International Recent Developments/Updates

Table 85. SPI Pharma Corporation Information

Table 86. SPI Pharma Description and Business Overview

Table 87. SPI Pharma Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. SPI Pharma Oral Vaccine Adjuvants Product

Table 89. SPI Pharma Recent Developments/Updates

Table 90. Phibro Animal Health Corporation Corporation Information

Table 91. Phibro Animal Health Corporation Description and Business Overview

Table 92. Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Phibro Animal Health Corporation Oral Vaccine Adjuvants Product

Table 94. Phibro Animal Health Corporation Recent Developments/Updates

Table 95. Tj Kaiwei Corporation Information

Table 96. Tj Kaiwei Description and Business Overview

Table 97. Tj Kaiwei Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Tj Kaiwei Oral Vaccine Adjuvants Product

Table 99. Tj Kaiwei Recent Developments/Updates

Table 100. Novavax Corporation Information

Table 101. Novavax Description and Business Overview

Table 102. Novavax Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Novavax Oral Vaccine Adjuvants Product

Table 104. Novavax Recent Developments/Updates

Table 105. Zhuoyue Corporation Information

Table 106. Zhuoyue Description and Business Overview

Table 107. Zhuoyue Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Zhuoyue Oral Vaccine Adjuvants Product

Table 109. Zhuoyue Recent Developments/Updates

Table 110. Aphios Corporation Information

Table 111. Aphios Description and Business Overview

Table 112. Aphios Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Aphios Oral Vaccine Adjuvants Product

Table 114. Aphios Recent Developments/Updates

Table 115. GSK Corporation Information

Table 116. GSK Description and Business Overview

Table 117. GSK Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. GSK Oral Vaccine Adjuvants Product

Table 119. GSK Recent Developments/Updates

Table 120. CSL Corporation Information

Table 121. CSL Description and Business Overview

Table 122. CSL Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. CSL Oral Vaccine Adjuvants Product

Table 124. CSL Recent Developments/Updates

Table 125. Brenntag Biosector Corporation Information

Table 126. Brenntag Biosector Description and Business Overview

Table 127. Brenntag Biosector Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Brenntag Biosector Oral Vaccine Adjuvants Product

Table 129. Brenntag Biosector Recent Developments/Updates

Table 130. SEPPIC Corporation Information

Table 131. SEPPIC Description and Business Overview

Table 132. SEPPIC Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. SEPPIC Oral Vaccine Adjuvants Product

Table 134. SEPPIC Recent Developments/Updates

Table 135. SPI Pharma Corporation Information

Table 136. SPI Pharma Description and Business Overview

Table 137. SPI Pharma Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. SPI Pharma Oral Vaccine Adjuvants Product

Table 139. SPI Pharma Recent Developments/Updates

Table 140. Novavax Corporation Information

Table 141. Novavax Description and Business Overview

Table 142. Novavax Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Novavax Oral Vaccine Adjuvants Product

Table 144. Novavax Recent Developments/Updates

Table 145. Avanti Polar Lipids Corporation Information

Table 146. Avanti Polar Lipids Description and Business Overview

Table 147. Avanti Polar Lipids Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Avanti Polar Lipids Oral Vaccine Adjuvants Product

Table 149. Avanti Polar Lipids Recent Developments/Updates

Table 150. Aphios Corporation Information

Table 151. Aphios Description and Business Overview

Table 152. Aphios Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Aphios Oral Vaccine Adjuvants Product

Table 154. Aphios Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Oral Vaccine Adjuvants Distributors List

Table 158. Oral Vaccine Adjuvants Customers List

Table 159. Oral Vaccine Adjuvants Market Trends

Table 160. Oral Vaccine Adjuvants Market Drivers

Table 161. Oral Vaccine Adjuvants Market Challenges

Table 162. Oral Vaccine Adjuvants Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Oral Vaccine Adjuvants

Figure 2. Global Oral Vaccine Adjuvants Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Oral Vaccine Adjuvants Market Share by Type in 2023 & 2030

Figure 4. Veterinary Vaccine Adjuvants Product Picture

Figure 5. Human Vaccine Adjuvants Product Picture

Figure 6. Global Oral Vaccine Adjuvants Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Oral Vaccine Adjuvants Market Share by Application in 2023 & 2030

Figure 8. Research Application

Figure 9. Commercial Application

Figure 10. Global Oral Vaccine Adjuvants Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Oral Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)

Figure 12. Global Oral Vaccine Adjuvants Sales (2019-2030) & (K Units)

Figure 13. Global Oral Vaccine Adjuvants Average Price (US$/Unit) & (2019-2030)

Figure 14. Oral Vaccine Adjuvants Report Years Considered

Figure 15. Oral Vaccine Adjuvants Sales Share by Manufacturers in 2023

Figure 16. Global Oral Vaccine Adjuvants Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Oral Vaccine Adjuvants Players: Market Share by Revenue in 2023

Figure 18. Oral Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Oral Vaccine Adjuvants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Oral Vaccine Adjuvants Sales Market Share by Country (2019-2030)

Figure 21. North America Oral Vaccine Adjuvants Revenue Market Share by Country (2019-2030)

Figure 22. United States Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Oral Vaccine Adjuvants Sales Market Share by Country (2019-2030)

Figure 25. Europe Oral Vaccine Adjuvants Revenue Market Share by Country (2019-2030)

Figure 26. Germany Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Oral Vaccine Adjuvants Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Oral Vaccine Adjuvants Revenue Market Share by Region (2019-2030)

Figure 33. China Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Oral Vaccine Adjuvants Sales Market Share by Country (2019-2030)

Figure 43. Latin America Oral Vaccine Adjuvants Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Oral Vaccine Adjuvants Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Oral Vaccine Adjuvants Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Oral Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Oral Vaccine Adjuvants by Type (2019-2030)

Figure 53. Global Revenue Market Share of Oral Vaccine Adjuvants by Type (2019-2030)

Figure 54. Global Oral Vaccine Adjuvants Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Oral Vaccine Adjuvants by Application (2019-2030)

Figure 56. Global Revenue Market Share of Oral Vaccine Adjuvants by Application (2019-2030)

Figure 57. Global Oral Vaccine Adjuvants Price (US$/Unit) by Application (2019-2030)

Figure 58. Oral Vaccine Adjuvants Value Chain

Figure 59. Oral Vaccine Adjuvants Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions